Sylvia Haas

6PUBLICATIONS
24CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Gene expression (incl. microarray and other genome-wide approaches)Immunogenetics (incl. genetic immunology)Cardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 28, 2024
Causes of death in patients with atrial fibrillation anticoagulated with rivaroxaban: a pooled analysis of XANTUS.

Paulus Kirchhof, Sylvia Haas, Pierre Amarenco

|Jun 09, 2023
Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AF.

Alan John Camm, Jan Steffel, Saverio Virdone

|Sep 12, 2022
GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide.

Sylvia Haas, John A Camm, Darius Harald

|Oct 29, 2021
Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: Data from GARFIELD-VTE.

Omri Cohen, Walter Ageno, Alfredo E Farjat

|Sep 06, 2021
Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD-VTE.

Jeffrey I Weitz, Alfredo E Farjat, Walter Ageno

|Apr 23, 2021
GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation.

Keith A A Fox, Saverio Virdone, Karen S Pieper

Pageof 1